The most notable shared upregulated gene was GFAP (glial fibrillary acidic protein; involved in astrocyte reactivity92,93), a promising biomarker for AD, with increased expression observed in corticospinal fluid and blood of AD patients94–98. Here, GFAP is linked to Alzheimer disease.